5FKJ | Hydrolase | date | Oct 16, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Mouse Acetylcholinesterase In Complex W An Alkyl Ammonium Derivative Of 6-Methyl Uracil | ||||||||||||||
authors | F.Nachon, M.Villard-Wandhammer, K.Petrov, P.Masson | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Acetylcholinesterase Chain: A, B, C, D Fragment: Unp Residues 32-574 Ec: 3.1.1.7 Engineered: Yes |
Organism_scientific: Mus Musculus Organism_common: House Mouse Organism_taxid: 10090 Expression_system: Cricetulus Griseus Expression_system_common: Chinese Hamster Expression_system_taxid: 10029 Expression_system_cell_line: Cho-K1 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pgs | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.13 Å | ||||||||||||
ligand | CL, G0W, NAG, SO4 | enzyme | Hydrolase E.C.3.1.1.7 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment., Kharlamova AD, Lushchekina SV, Petrov KA, Kots ED, Nachon F, Villard-Wandhammer M, Zueva IV, Krejci E, Reznik VS, Zobov VV, Nikolsky EE, Masson P, Biochem J. 2016 May 1;473(9):1225-36. doi: 10.1042/BCJ20160084. Epub 2016 Feb 29. PMID:26929400 |
Data retrieval |
View 5FKJ in 3D |
Visual 3D analysis of 5FKJ |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5FKJ |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |